Current Analysis: Elekta AB [EKTAF]
June 17, 2024 at 22:09 PM EDT
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy. Over the past year, Elekta's share price dropped 17.3% from $8.34 to $6.28 as of Monday’s market close.
